RxSight, Inc. Announces Chief Financial Officer Transition - RxSight (NASDAQ:RXST)

RxSight, Inc. Announces Chief Financial Officer Transition - RxSight (NASDAQ:RXST)

ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that Shelley Thunen, the Company's Chief Financial Officer, is transitioning from her role. Ms. Thunen will remain with the Company until the sooner of the appointment of her successor or January 31, 2026. Ms. Thunen has agreed to s…

Cataract-vision device maker RxSight shifts CFO after nearly a decade

RxSight says CFO Shelley Thunen will stay until a successor is appointed or Jan. 31, 2026, after guiding it to 1,100 LDDs and over quarter million procedures.